KGKara L. Gavin

Kara L. Gavin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kara L. Gavin has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient-reported distress and correlates while on adjuvant endocrine therapy following breast cancer treatment among post-menopausal women: a group-based trajectory model analysis

    by Kara L. Gavin, Jacob Tiegs, Aaron N. Winn, Vaia Makris, Joan M. Neuner, Kathryn E. Flynn

    Purpose: To examine changes in patient-reported distress in female breast cancer (hormone-receptor-positive, stages 1–3) patients aged 55 + taking adjuvant endocrine therapy (AET). Methods: A retrospective cohort was constructed using the electronic health record (EHR) at a single Midwestern site from 2014 to 2019. Patients ( N = 390) were included if they had completed two or more distress thermometer (DT) assessments. The DT is scored from 0 to 10; four is the threshold for clinically concerning distress. Trajectories were assigned using group-based trajectory modeling analyses. Predictors of group membership were identified using a cross-validated lasso algorithm. Results: The best-fit model included four groups. Group 1 (22%) had no distress, Group 2 (29%) had low distress (average DT = 0.8) that remained low, Group 3 (33%) had medium–low distress (2.7) that remained low, and Group 4 (16%) had high distress (6.2) that decreased but remained high (5) over time. Higher initial DT value was associated with a decreased odds of membership in Group 1 (OR = 0.88; 95% CI (0.80–0.95)) and increased in Group 4 (OR = 1.14; 95% CI (1.06–1.25)). Endorsement of sleep issues was associated with decreased odds of membership in Group 1 (OR = 0.59; 95% CI (0.40–0.87)) and increased odds of membership in Group 3 (OR = 1.53; 95% CI (1.11–2.26)). Conclusion: The majority of post-menopausal women do not report distress while taking AET; however, one in six reports high distress that did not dissipate with time. This work adds to the understanding of distress in breast cancer survivors and supports the use of the DT in providing actionable information on distress and its causes.

  • Differences in GLP-1 RA medication adherence across place-based variables in patients with diabetes living in Wisconsin

    by Kara L. Gavin, Rabia Amjad, Vaia Makris, Joan M. Neuner

    Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications are efficacious in improving health outcomes in patients with type 2 diabetes mellitus (T2DM). As demand and costs have increased, questions have arisen around socioeconomic and geographic differences in adherence. To understand these differences, pharmacy claims data were used to examine medication fills across urban and rural areas and Census tract-level income and racial make-up. Data obtained from the Wisconsin Health Information Organization database included adults (aged ≥18 years) diagnosed with T2DM, with a prescription fill for a GLP-1 RA medication between January 1, 2020, and September 30, 2022. Adherence was defined as proportion of prescription days covered of 80% or greater for 1 year from first fill. Unadjusted and adjusted logistic regression was performed. Adherence was compared across urban and rural residence and Census tract-level median household income quintiles and race (majority Black residents vs nonmajority, majority Hispanic residents vs nonmajority, and majority White residents vs nonmajority). Adjusted models included age, sex, insurance provider, and number of comorbidities. Patients (N = 7,265) were 56.3% female with a mean age of 55.3 (SD = 12.1) years. Place-based variables showed 38.2% lived in rural areas, 5.8% lived in areas with majority Black population, 2.0% with majority Hispanic population, and 87.9% with majority White population. Overall, 40.1% of patients were adherent 1 year following first prescription fill. Adjusted models showed that patients in tracts with the lowest incomes had lower odds of adherence compared with those living in the highest income tracts (odds ratio [OR] = 0.76; 95% CI = 0.59-0.98). Patients in areas with majority Black residents had lower odds of adherence (OR = 0.67; 95% CI = 0.52-0.85) than areas with less than a majority of Black residents, whereas patients living in areas with majority White residents had higher odds of adherence (OR = 1.31; 95% CI = 1.11-1.56) than areas with less than a majority of White residents. This analysis highlights geographic differences in medication adherence in patients with T2DM. Patients living in high-income areas and areas with higher percentages of White residents had higher odds of adherence to GLP-1 RA medications. As demand for GLP-1 RA medications grow, future work that identifies reasons for disparities in adherence and potential strategies to improve adherence is critical.


  • Small Monetary Incentives Lead to Greater Adherence in a Weight Loss Program

    by Armaan Shetty, Qiuyu Yang, Jane Pendergast, Glen Leverson, Ryan Shaw, Corrine I. Voils, Kara L. Gavin

    Purpose: Understand how weekly monetary incentives for dietary tracking and/or weight loss impact 6-month weight loss behavioral adherence. Design: Secondary analysis of participants randomized to one of four conditions in a behavioral weight loss intervention: incentives for dietary tracking, incentives for weight loss, both, or none. Setting: Participants were asked to self-weigh at least twice weekly, log food and drink in a mobile application five days weekly, and attend bi-weekly, group-based classes. Sample: Data from (n = 91) adults with obesity who completed a 24-week behavioral weight loss intervention of whom 88% were female and 74% Non-Hispanic White, were analyzed. Measures: Non-adherence to weight and dietary self-monitoring was defined as the second week of not meeting criteria. Class attendance was also tracked. Analysis: Kaplan-Meier analyses were used to examine differences across the four conditions. Results: Participants incentivized for dietary self-monitoring had an average 15.8 weeks (SE:1.2) until the first non-adherent week compared to 5.9 weeks (SE:0.8) for those not incentivized for dietary self-monitoring ( P < .01). Those incentivized for weight loss had an average 18.0 weeks (SE:1.02) of self-weighing until the first non-adherent week compared to 13.5 weeks (SE:1.3) for those not incentivized for weight loss ( P = .02). No difference in class attendance was observed. Conclusions: Incentivizing behaviors associated with weight loss improved adherence to those behaviors and does not appear to spill over to non-incentivized behaviors.


  • Open Access

    An Adaptive Optimization Approach to Personalized Financial Incentives in Mobile Behavioral Weight Loss Interventions

    by Qiaomei Li, Kara L. Gavin, Corrine I. Voils, Yonatan Mintz

    Obesity is a critical healthcare issue affecting the United States. The least risky treatments available for obesity are behavioral interventions meant to promote diet and exercise. Often these interventions contain a mobile component that allows interventionists to collect participants level data and provide participants with incentives and goals to promote long term behavioral change. Recently, there has been interest in using direct financial incentives to promote behavior change. However, adherence is challenging in these interventions, as each participant will react differently to different incentive structure and amounts, leading researchers to consider personalized interventions. The key challenge for personalization, is that the clinicians do not know a priori how best to administer incentives to participants, and given finite intervention budgets how to disburse costly resources efficiently. In this paper, we consider this challenge of designing personalized weight loss interventions that use direct financial incentives to motivate weight loss while remaining within a budget. We create a machine learning approach that is able to predict how individuals may react to different incentive schedules within the context of a behavioral intervention. We use this predictive model in an adaptive framework that over the course of the intervention computes what incentives to disburse to participants and remain within the study budget. We provide both theoretical guarantees for our modeling and optimization approaches as well as demonstrate their performance in a simulated weight loss study. Our results highlight the cost efficiency and effectiveness of our personalized intervention design for weight loss.

  • Open Access

    Comparison of weight captured via electronic health record and cellular scales to the gold‐standard clinical method

    by Kara L. Gavin, Emily J. Almeida, Corrine I. Voils, Melissa M. Crane, Ryan Shaw, William S. Yancy, Jane Pendergast, Maren K. Olsen

    IntroductionObtaining body weights remotely could improve feasibility of pragmatic trials. This investigation examined whether weights collected via cellular scale or electronic health record (EHR) correspond to gold standard in-person study weights. MethodsThe agreement of paired weight measurements from cellular scales were compared to study scales from a weight loss intervention and EHR-collected weights were compared to study scales from a weight loss maintenance intervention. Differential weight change estimates between intervention and control groups using both pragmatic methods were compared to study collected weight. In the Log2Lose feasibility weight loss trial, in-person weights were collected bi-weekly and compared to weights collected via cellular scales throughout the study period. In the MAINTAIN weight loss maintenance trial, in-person weights were collected at baseline, 14, 26, 42 and 56 weeks. All available weights from the EHR during the study period were obtained. ResultsOn average, in Log2Lose cellular scale weights were 0.6 kg (95% CI: -2.9, 2.2) lower than in-person weights; in MAINTAIN, EHR weights were 2.8 kg (SE: -0.5, 6.0) higher than in-person weights. Estimated weight change using pragmatic methods and study scales in both studies were in the same direction and of similar magnitude. ConclusionBoth methods can be used as cost-effective and real-world surrogates within a tolerable variability for the gold-standard. Trial registrationNCT02691260; NCT01357551.


  • Open Access

    A Method to Deliver Automated and Tailored Intervention Content: 24-month Clinical Trial

    by Hailey N Miller, Corrine I Voils, Kate A Cronin, Elizabeth Jeanes, Jeffrey Hawley, Laura S Porter, Rachel R Adler, Whitney Sharp, Samantha Pabich, Kara L Gavin, et al.

    Background: The use of digital technologies and software allows for new opportunities to communicate and engage with research participants over time. When software is coupled with automation, we can engage with research participants in a reliable and affordable manner. Research Electronic Data Capture (REDCap), a browser-based software, has the capability to send automated text messages. This feature can be used to automate delivery of tailored intervention content to research participants in interventions, offering the potential to reduce costs and improve accessibility and scalability. Objective: This study aimed to describe the development and use of 2 REDCap databases to deliver automated intervention content and communication to index participants and their partners (dyads) in a 2-arm, 24-month weight management trial, Partner2Lose. Methods: Partner2Lose randomized individuals with overweight or obesity and cohabitating with a partner to a weight management intervention alone or with their partner. Two databases were developed to correspond to 2 study phases: one for weight loss initiation and one for weight loss maintenance and reminders. The weight loss initiation database was programmed to send participants (in both arms) and their partners (partner-assisted arm) tailored text messages during months 1-6 of the intervention to reinforce class content and support goal achievement. The weight maintenance and reminder database was programmed to send maintenance-related text messages to each participant (both arms) and their partners (partner-assisted arm) during months 7-18. It was also programmed to send text messages to all participants and partners over the course of the 24-month trial to remind them of group classes, dietary recall and physical activity tracking for assessments, and measurement visits. All text messages were delivered via Twilio and were unidirectional. Results: Five cohorts, comprising 231 couples, were consented and randomized in the Partner2Lose trial. The databases will send 53,518 automated, tailored text messages during the trial, significantly reducing the need for staff to send and manage intervention content over 24 months. The cost of text messaging will be approximately US $450. Thus far, there is a 0.004% known error rate in text message delivery. Conclusions: Our trial automated the delivery of tailored intervention content and communication using REDCap. The approach described provides a framework that can be used in future behavioral health interventions to create an accessible, reliable, and affordable method for intervention delivery and engagement that requires minimal trial-specific resources and personnel time. Trial Registration: ClinicalTrials.gov NCT03801174; https://clinicaltrials.gov/ct2/show/NCT03801174?term=NCT03801174


  • Open Access

    Two‐year weight trajectories following completion of a behavioral weight loss maintenance intervention

    by Kara L. Gavin, Corrine I. Voils, William S. Yancy, Maren K. Olsen

    Introduction: Long‐term effects of behavioral weight loss maintenance interventions need to be assessed in order to understand their durability of effects. This can be evaluated with the use of weights recorded in the electronic medical record. The goal of this study was to use electronic health record (EHR)‐recorded weight to examine outcomes 2 years beyond the completion of a trial in which participants were randomized to receive a weight maintenance intervention or usual care after required initial weight loss.Methods: Weights collected in the Veteran's Affairs national EHR were obtained for 2 years following trial completion. Outliers and implausible weights were identified and removed prior to analysis. Mixed‐effects models with quadratic time were fit to estimate between‐arm differences in weight change.Results: Model‐estimated weight at trial completion was 109.7 kg for usual care and 106.8 kg for intervention, estimated difference of −2.9 kg (95% confidence interval [CI]: −8.8, 3.0; p = 0.34). Two years later, estimated mean weight collected from (n = 211) participants with available EMR weights was 111.5 kg for usual care and 108.0 kg for intervention, estimated difference −3.4 kg (95% CI: −9.3, 2.4 kg; p = 0.35).Conclusions: While not statistically significant, weights from the EHR suggest the possibility of a clinically meaningful difference that should be confirmed by future adequately powered studies.


  • Optimization of a technology-supported physical activity intervention for breast cancer survivors: Fit2Thrive study protocol

    by Siobhan M. Phillips, Linda M. Collins, Frank J. Penedo, Kerry S. Courneya, Whitney Welch, Alison Cottrell, Gillian R. Lloyd, Kara Gavin, David Cella, Ronald T. Ackermann, et al.


  • Open Access

    Weighing frequency among working adults: Cross-sectional analysis of two community samples

    by Kara L. Gavin, Jennifer A. Linde, Carly R. Pacanowski, Simone A. French, Robert W. Jeffery, Yen-Yi Ho